CVS Pulling Popular Cold Meds From Shelves After Report Deems Them to Be Useless
FRIDAY, Oct. 20, 2023 (HealthDay News) -- CVS Health plans to pull cold medications that contain phenylephrine from its store shelves after federal regulators determined recently that the decongestant does not work.
Oral phenylephrine is an active ingredient in such well-known products as Sudafed and Dayquil. A U.S. Food and Drug Administration advisory committee ruled last month that the ingredient was useless in easing congestion.
"We are removing certain oral cough and cold products that contain phenylephrine as the only active ingredient from CVS Pharmacy stores," the company told CBS MoneyWatch. "Other oral cough and cold products will continue to be offered to meet consumer needs."
Another drugstore chain, Walgreens, said it "follows FDA regulations," but did not say if it would stop selling the medications.
"We are closely monitoring the situation and actively partnering with the Walgreens Office of Clinical Integrity and suppliers on appropriate next steps," a spokesperson told CBS MoneyWatch.
Medications that contain phenylephrine account for $1.8 billion in annual sales, according to FDA data.
Related Posts
Hormone Replacement Therapy Won’t Raise Recurrence Rate for Breast Cancer Survivors
WEDNESDAY, July 20, 2022 (HealthDay News) -- Hormone replacement therapy (HRT)...
Long-Term Health Consequences Seen for Stroke in Pregnancy
TUESDAY, Jan. 24, 2023 (HealthDay News) -- Long-term health consequences are...
Balanced Multielectrolyte Solution No Benefit for Patients in ICU
MONDAY, Jan. 31, 2022 (HealthDay News) -- For critically ill patients in the...